Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth

Hepatocellular carcinoma (HCC) is the most prevalent type of liver cancer. No significant improvement has been reported with currently available systemic therapies. IFN-α has been tested in both clinic and animal models and only moderate benefits have been observed. In animal models, similar modest...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasfar, Ahmed, de la Torre, Andrew, Abushahba, Walid, Cohen-Solal, Karine A, Castaneda, Ismael, Yuan, Yao, Reuhl, Kenneth, Zloza, Andrew, Raveche, Elizabeth, Laskin, Debra L, Kotenko, Sergei V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226505/
https://www.ncbi.nlm.nih.gov/pubmed/27363032
http://dx.doi.org/10.18632/oncotarget.10272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226505/
https://www.ncbi.nlm.nih.gov/pubmed/27363032
http://dx.doi.org/10.18632/oncotarget.10272

Ejemplares similares